View in EDS

Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.

Saved in:
Bibliographic Details
Title: Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
Authors: Lim SM; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Kang SS; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Kim DK; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Lee SH; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea., Synn CB; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Baek S; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Yang SM; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han YJ; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim MH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Han H; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Na K; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YT; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea., Yun MR; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Kim JH; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Byeon Y; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Kim YS; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea., Lee JB; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Hong MH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea., Curtin JC; Janssen R&D, Spring House, Pennsylvania., Patel B; Janssen R&D, Spring House, Pennsylvania., Bergiers I; Janssen R&D, Beerse, Belgium., Pyo KH; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea., Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea.
Source: Cancer research communications [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1748-1764.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38916448
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lim+SM%22">Lim SM</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kang+SS%22">Kang SS</searchLink>; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+DK%22">Kim DK</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+SH%22">Lee SH</searchLink>; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.<br /><searchLink fieldCode="AU" term="%22Synn+CB%22">Synn CB</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Baek+S%22">Baek S</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Yang+SM%22">Yang SM</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Han+YJ%22">Han YJ</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+MH%22">Kim MH</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Na+K%22">Na K</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YT%22">Kim YT</searchLink>; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Yun+MR%22">Yun MR</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+JH%22">Kim JH</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Byeon+Y%22">Byeon Y</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Kim+YS%22">Kim YS</searchLink>; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JB%22">Lee JB</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Hong+MH%22">Hong MH</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Curtin+JC%22">Curtin JC</searchLink>; Janssen R&D, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Patel+B%22">Patel B</searchLink>; Janssen R&D, Spring House, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Bergiers+I%22">Bergiers I</searchLink>; Janssen R&D, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Pyo+KH%22">Pyo KH</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea.<br /><searchLink fieldCode="AU" term="%22Cho+BC%22">Cho BC</searchLink>; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea.; JEUK Institute for Cancer Research, JEUK Co., Ltd., Gumi-si, South Korea.; Brain Korea 21 PLUS Project for Medical Science, College of Medicine, Yonsei University, Seoul, South Korea.; Department of Research Support, Yonsei Biomedical Research Institute, Yonsei University College of Medicine, Seoul, South Korea.; Yonsei New Il Han Institute for Integrative Lung Cancer Research, Seoul, South Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918281580506676%22">Cancer research communications</searchLink> [Cancer Res Commun] 2024 Jul 01; Vol. 4 (7), pp. 1748-1764.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9918281580506676 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2767-9764 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227679764%22">27679764 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Res Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38916448
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2767-9764.CRC-24-0107
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1748
    Titles:
      – TitleFull: Exploration of Immune-Modulatory Effects of Amivantamab in Combination with Pembrolizumab in Lung and Head and Neck Squamous Cell Carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lim SM
      – PersonEntity:
          Name:
            NameFull: Kang SS
      – PersonEntity:
          Name:
            NameFull: Kim DK
      – PersonEntity:
          Name:
            NameFull: Lee SH
      – PersonEntity:
          Name:
            NameFull: Synn CB
      – PersonEntity:
          Name:
            NameFull: Baek S
      – PersonEntity:
          Name:
            NameFull: Yang SM
      – PersonEntity:
          Name:
            NameFull: Han YJ
      – PersonEntity:
          Name:
            NameFull: Kim MH
      – PersonEntity:
          Name:
            NameFull: Han H
      – PersonEntity:
          Name:
            NameFull: Na K
      – PersonEntity:
          Name:
            NameFull: Kim YT
      – PersonEntity:
          Name:
            NameFull: Yun MR
      – PersonEntity:
          Name:
            NameFull: Kim JH
      – PersonEntity:
          Name:
            NameFull: Byeon Y
      – PersonEntity:
          Name:
            NameFull: Kim YS
      – PersonEntity:
          Name:
            NameFull: Lee JB
      – PersonEntity:
          Name:
            NameFull: Hong MH
      – PersonEntity:
          Name:
            NameFull: Curtin JC
      – PersonEntity:
          Name:
            NameFull: Patel B
      – PersonEntity:
          Name:
            NameFull: Bergiers I
      – PersonEntity:
          Name:
            NameFull: Pyo KH
      – PersonEntity:
          Name:
            NameFull: Cho BC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2024 Jul 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2767-9764
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Cancer research communications
              Type: main
ResultId 1